Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the FINDER® Flu A&B/SARS-CoV-2 Test, an ultra-rapid ...

In 2022, ALPCO merged with GeneProof, a Czech Republic-based provider of specialty molecular diagnostic solutions. Founded in 2005, GeneProof offers a portfolio of more than 50 IVDD and 6 IVDR PCR ...

Biomarker testing identifies high-risk early-stage NSCLC patients for adjuvant chemotherapy, reducing recurrence risk by 78%. The AIM-HIGH study shows a 96% disease-free survival rate at 24 months ...

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced that a broad portfolio of its Alethia molecular assays has ...

LANSING, Mich., April 30, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), a worldwide leader in innovative solutions that help the food and beverage ...

This article offers a comprehensive review of the latest diagnostic tools developed for detecting Monkeypox virus (MPXV), especially in light of recent outbreaks. The authors focus on two major ...

Symeres has entered a collaboration with Ambagon Therapeutics on molecular glue research in colorectal cancer, aiming to ...

Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001 Ductal carcinoma in situ (DCIS) is routinely treated with ...

Please provide your email address to receive an email when new articles are posted on . A 14-gene molecular assay may help predict adjuvant chemotherapy benefit in early NSCLC. Patients assigned ...

The raised price target from $8 to $12 puts Insight Molecular Diagnostics more firmly on the radar for investors tracking valuation shifts. Analysts are linking this higher price target to the recent ...